- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- NX-1207, Placebo
- Drug
- Lead sponsor
- Nymox Corporation
- Industry
- Eligibility
- 45 Years and older · Male only
- Enrollment
- 500 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2013
- U.S. locations
- 41
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Tucson, Arizona + 38 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–6
of 6
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Benign Prostatic Hyperplasia, BPH, Lower Urinary Tract Symptoms (LUTS), LUTS
- Interventions
- NX-1207
- Drug
- Lead sponsor
- Nymox Corporation
- Industry
- Eligibility
- 45 Years and older · Male only
- Enrollment
- 160 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 17
- States / cities
- Laguna Beach, California • San Diego, California • Aventura, Florida + 14 more
- Conditions
- Prostate Cancer
- Interventions
- NX-1207 2.5 mg, NX-1207 15 mg
- Drug
- Lead sponsor
- Nymox Corporation
- Industry
- Eligibility
- 45 Years to 85 Years · Male only
- Enrollment
- 141 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 23
- States / cities
- Tucson, Arizona • Atherton, California • La Mesa, California + 20 more
- Conditions
- Benign Prostatic Hyperplasia (BPH)
- Interventions
- NX-1207, Placebo
- Drug
- Lead sponsor
- Nymox Corporation
- Industry
- Eligibility
- 45 Years and older · Male only
- Enrollment
- 500 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2014
- U.S. locations
- 35
- States / cities
- Laguna Hills, California • San Diego, California • Tarzana, California + 30 more
- Conditions
- Benign Prostatic Hyperplasia (BPH), Enlarged Prostate
- Interventions
- 2.5 mg NX-1207, 0.125 mg NX-1207, finasteride
- Drug
- Lead sponsor
- Nymox Corporation
- Industry
- Eligibility
- 45 Years to 75 Years · Male only
- Enrollment
- 85 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 30
- States / cities
- Huntsville, Alabama • Tucson, Arizona • Little Rock, Arkansas + 27 more
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- NX-1207
- Drug
- Lead sponsor
- Nymox Corporation
- Industry
- Eligibility
- 45 Years and older · Male only
- Enrollment
- 192 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2013
- U.S. locations
- 28
- States / cities
- Huntsville, Alabama • Atherton, California • San Diego, California + 25 more